Blood, ISSN 0006-4971, 06/2016, Volume 127, Issue 25, pp. 3133 - 3141
Left ventricular assist devices (LVAD) provide cardiac support for patients with endstage heart disease as either bridge or destination therapy, and have...
HUMAN VONWILLEBRAND-FACTOR | ADVANCED HEART-FAILURE | ARTERIOVENOUS-MALFORMATIONS | INDUCED PLATELET-AGGREGATION | FACTOR-VIII BINDING | MECHANICAL CIRCULATORY SUPPORT | ENDOTHELIAL-CELLS | INTERMACS ANNUAL-REPORT | CONTINUOUS-FLOW | GLYCOPROTEIN-IB | HEMATOLOGY | Heart Failure - surgery | Ventricular Dysfunction, Left - surgery | Hemostasis - physiology | Thrombosis - etiology | von Willebrand Factor - physiology | Humans | Heart Transplantation - adverse effects | Heart Transplantation - instrumentation | Heart-Assist Devices - adverse effects | Ventricular Dysfunction, Left - physiopathology | von Willebrand Diseases - etiology | Review
HUMAN VONWILLEBRAND-FACTOR | ADVANCED HEART-FAILURE | ARTERIOVENOUS-MALFORMATIONS | INDUCED PLATELET-AGGREGATION | FACTOR-VIII BINDING | MECHANICAL CIRCULATORY SUPPORT | ENDOTHELIAL-CELLS | INTERMACS ANNUAL-REPORT | CONTINUOUS-FLOW | GLYCOPROTEIN-IB | HEMATOLOGY | Heart Failure - surgery | Ventricular Dysfunction, Left - surgery | Hemostasis - physiology | Thrombosis - etiology | von Willebrand Factor - physiology | Humans | Heart Transplantation - adverse effects | Heart Transplantation - instrumentation | Heart-Assist Devices - adverse effects | Ventricular Dysfunction, Left - physiopathology | von Willebrand Diseases - etiology | Review
Journal Article
Circulation, ISSN 0009-7322, 02/2011, Volume 123, Issue 4, pp. 381 - 390
Background-We have previously shown that a specific combination of drug therapy and left ventricular assist device unloading results in significant myocardial...
heart failure | heart-assist device | cardiomyopathy | cardiac transplantation | SUPPORT | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL RECOVERY | CLENBUTEROL | CARDIAC-HYPERTROPHY | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Severity of Illness Index | Prospective Studies | Humans | Middle Aged | Stroke Volume - drug effects | Male | Treatment Outcome | Heart Failure - drug therapy | Young Adult | Cardiovascular Agents - therapeutic use | Heart Failure - therapy | Ventricular Dysfunction, Left - therapy | Ventricular Dysfunction, Left - drug therapy | Cardiomyopathy, Dilated - drug therapy | Clenbuterol - therapeutic use | Adult | Female | Heart-Assist Devices | Cardiomyopathy, Dilated - therapy | Heart failure | Care and treatment | Patient outcomes
heart failure | heart-assist device | cardiomyopathy | cardiac transplantation | SUPPORT | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL RECOVERY | CLENBUTEROL | CARDIAC-HYPERTROPHY | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Severity of Illness Index | Prospective Studies | Humans | Middle Aged | Stroke Volume - drug effects | Male | Treatment Outcome | Heart Failure - drug therapy | Young Adult | Cardiovascular Agents - therapeutic use | Heart Failure - therapy | Ventricular Dysfunction, Left - therapy | Ventricular Dysfunction, Left - drug therapy | Cardiomyopathy, Dilated - drug therapy | Clenbuterol - therapeutic use | Adult | Female | Heart-Assist Devices | Cardiomyopathy, Dilated - therapy | Heart failure | Care and treatment | Patient outcomes
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2009, Volume 54, Issue 4, pp. 312 - 321
Objectives This study sought to evaluate the use of a continuous-flow rotary left ventricular assist device (LVAD) as a bridge to heart transplantation....
Cardiovascular | Internal Medicine | heart failure | heart transplantation | left ventricular assist device | SYSTEM | AWAITING HEART-TRANSPLANTATION | CARDIAC & CARDIOVASCULAR SYSTEMS | CLINICAL-TRIAL | DESTINATION THERAPY | BLOOD-PUMPS | RELIABILITY | CANDIDATES | BRIDGE | Heart Failure - therapy | Humans | Middle Aged | Quality of Life | Adult | Female | Heart Transplantation | Male | Treatment Outcome | Heart-Assist Devices | Heart failure | Universities and colleges | Heart | Medical colleges | Infections | FDA approval | Transplants & implants | Drug therapy | Quality of life
Cardiovascular | Internal Medicine | heart failure | heart transplantation | left ventricular assist device | SYSTEM | AWAITING HEART-TRANSPLANTATION | CARDIAC & CARDIOVASCULAR SYSTEMS | CLINICAL-TRIAL | DESTINATION THERAPY | BLOOD-PUMPS | RELIABILITY | CANDIDATES | BRIDGE | Heart Failure - therapy | Humans | Middle Aged | Quality of Life | Adult | Female | Heart Transplantation | Male | Treatment Outcome | Heart-Assist Devices | Heart failure | Universities and colleges | Heart | Medical colleges | Infections | FDA approval | Transplants & implants | Drug therapy | Quality of life
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2011, Volume 57, Issue 19, pp. 1890 - 1898
Objectives: The aim of this study was to determine whether results with the HeartMate (HM) II left ventricular assist device (LVAD) (Thoratec Corporation,...
ventricular assist device | heart failure | cardiac transplantation | CARDIAC & CARDIOVASCULAR SYSTEMS | FAILURE PATIENTS | Ventricular Dysfunction, Left - surgery | Assisted Circulation - standards | Prospective Studies | Assisted Circulation - instrumentation | Follow-Up Studies | Registries - standards | United States | Humans | Middle Aged | Child, Preschool | Heart Transplantation - instrumentation | Infant | Male | Young Adult | Ventricular Dysfunction, Left - therapy | Product Surveillance, Postmarketing - standards | Device Approval - standards | Adult | Female | Product Surveillance, Postmarketing - methods | Child | Infant, Newborn | Heart Transplantation - standards | Adolescent | Aged | Heart-Assist Devices - standards | Confidence intervals | Heart failure | Survival analysis | Transplants & implants | Mortality | Clinical trials | FDA approval | Drug therapy | Quality of life
ventricular assist device | heart failure | cardiac transplantation | CARDIAC & CARDIOVASCULAR SYSTEMS | FAILURE PATIENTS | Ventricular Dysfunction, Left - surgery | Assisted Circulation - standards | Prospective Studies | Assisted Circulation - instrumentation | Follow-Up Studies | Registries - standards | United States | Humans | Middle Aged | Child, Preschool | Heart Transplantation - instrumentation | Infant | Male | Young Adult | Ventricular Dysfunction, Left - therapy | Product Surveillance, Postmarketing - standards | Device Approval - standards | Adult | Female | Product Surveillance, Postmarketing - methods | Child | Infant, Newborn | Heart Transplantation - standards | Adolescent | Aged | Heart-Assist Devices - standards | Confidence intervals | Heart failure | Survival analysis | Transplants & implants | Mortality | Clinical trials | FDA approval | Drug therapy | Quality of life
Journal Article
Journal of Thoracic Disease, ISSN 2072-1439, 2015, Volume 7, Issue 12, pp. 2194 - 2202
The domain of pediatric ventricular assist device (VAD) has recently gained considerable attention. Despite the fact that, historically, the practice of...
Ventricular assist device (VAD) | Children | Pediatric | Mechanical circulatory support (MCS) | BERLIN HEART EXCOR | THROMBOSIS | CIRCULATORY SUPPORT | mechanical circulatory support (MCS) | TRANSPLANTATION | children | IMPLANTATION | RESPIRATORY SYSTEM | FONTAN CIRCULATION | PATIENT | ventricular assist device (VAD) | INTERMACS ANNUAL-REPORT | OUTCOMES | Review on Left Ventricular Assist Devices
Ventricular assist device (VAD) | Children | Pediatric | Mechanical circulatory support (MCS) | BERLIN HEART EXCOR | THROMBOSIS | CIRCULATORY SUPPORT | mechanical circulatory support (MCS) | TRANSPLANTATION | children | IMPLANTATION | RESPIRATORY SYSTEM | FONTAN CIRCULATION | PATIENT | ventricular assist device (VAD) | INTERMACS ANNUAL-REPORT | OUTCOMES | Review on Left Ventricular Assist Devices
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2012, Volume 31, Issue 7, pp. 715 - 718
Background Continuous flow left ventricular assist devices (CF-LVADs) have yielded improved outcomes compared with pulsatile flow devices for patients on...
Surgery | gastrointestinal | heart failure | bleeding | left ventricular assist device | LVAD | SURGERY | VASCULAR ECTASIAS | CARDIAC & CARDIOVASCULAR SYSTEMS | AORTIC-STENOSIS | NONPULSATILE | LONG-TERM SUPPORT | CIRCULATORY SUPPORT | VON-WILLEBRAND-SYNDROME | CLINICAL-EXPERIENCE | TRANSPLANTATION | IMPLANTATION | RESPIRATORY SYSTEM | CAPSULE ENDOSCOPY | Recurrence | Prevalence | Gastrointestinal Hemorrhage - physiopathology | Heart-Assist Devices - classification | Humans | Middle Aged | Kaplan-Meier Estimate | Anticoagulants - therapeutic use | Male | Heart-Assist Devices - adverse effects | Anticoagulants - adverse effects | Gastrointestinal Hemorrhage - epidemiology | Heart Failure - therapy | Gastrointestinal Hemorrhage - etiology | Adult | Female | Retrospective Studies | Gastrointestinal bleeding
Surgery | gastrointestinal | heart failure | bleeding | left ventricular assist device | LVAD | SURGERY | VASCULAR ECTASIAS | CARDIAC & CARDIOVASCULAR SYSTEMS | AORTIC-STENOSIS | NONPULSATILE | LONG-TERM SUPPORT | CIRCULATORY SUPPORT | VON-WILLEBRAND-SYNDROME | CLINICAL-EXPERIENCE | TRANSPLANTATION | IMPLANTATION | RESPIRATORY SYSTEM | CAPSULE ENDOSCOPY | Recurrence | Prevalence | Gastrointestinal Hemorrhage - physiopathology | Heart-Assist Devices - classification | Humans | Middle Aged | Kaplan-Meier Estimate | Anticoagulants - therapeutic use | Male | Heart-Assist Devices - adverse effects | Anticoagulants - adverse effects | Gastrointestinal Hemorrhage - epidemiology | Heart Failure - therapy | Gastrointestinal Hemorrhage - etiology | Adult | Female | Retrospective Studies | Gastrointestinal bleeding
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2015, Volume 34, Issue 9, pp. 1123 - 1130
Most patients with advanced systolic dysfunction who are assessed for a left ventricular assist device (LVAD) also have some degree of right ventricular (RV)...
Surgery | peri-operative mortality | RVF predictors | left ventricular assist device | right ventricular failure | risk models | DIAMETER RATIO | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | MECHANICAL CIRCULATORY SUPPORT | INTERNATIONAL SOCIETY | CENTRIFUGAL PUMP | LVAD RECIPIENTS | PREDICTION | TRANSPLANTATION | RIGHT HEART-FAILURE | RISK-FACTOR | IMPLANTATION | RESPIRATORY SYSTEM | SPECKLE-TRACKING ECHOCARDIOGRAPHY | Echocardiography | Humans | Heart Failure - physiopathology | Heart Ventricles | Heart Failure - therapy | Models, Biological | Quality of Life | Hemodynamics | Chronic Disease | Heart Failure - etiology | Heart-Assist Devices | Postoperative Complications | Ventricular Function, Right | Diuretics | Health aspects | Analysis
Surgery | peri-operative mortality | RVF predictors | left ventricular assist device | right ventricular failure | risk models | DIAMETER RATIO | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | MECHANICAL CIRCULATORY SUPPORT | INTERNATIONAL SOCIETY | CENTRIFUGAL PUMP | LVAD RECIPIENTS | PREDICTION | TRANSPLANTATION | RIGHT HEART-FAILURE | RISK-FACTOR | IMPLANTATION | RESPIRATORY SYSTEM | SPECKLE-TRACKING ECHOCARDIOGRAPHY | Echocardiography | Humans | Heart Failure - physiopathology | Heart Ventricles | Heart Failure - therapy | Models, Biological | Quality of Life | Hemodynamics | Chronic Disease | Heart Failure - etiology | Heart-Assist Devices | Postoperative Complications | Ventricular Function, Right | Diuretics | Health aspects | Analysis
Journal Article
Heart, ISSN 1355-6037, 07/2015, Volume 101, Issue 14, pp. 1083 - 1084
[...]this condition remains highly lethal despite medical and pacemaker/defibrillator therapy, with an estimated 1-year freedom from hospitalisation or death...
CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | Heart Failure - therapy | Ventricular Function, Left | Heart-Assist Devices | Humans | Ventricular Function, Right | Heart | Postoperative period | Congenital diseases | Transplants & implants | Cardiovascular disease | Anatomy & physiology | Clinical outcomes
CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | Heart Failure - therapy | Ventricular Function, Left | Heart-Assist Devices | Humans | Ventricular Function, Right | Heart | Postoperative period | Congenital diseases | Transplants & implants | Cardiovascular disease | Anatomy & physiology | Clinical outcomes
Journal Article
Circulation, ISSN 0009-7322, 08/2012, Volume 126, Issue 7, pp. 866 - 874
heart failure | terminal care | quality of life | heart-assist devices | CARDIAC & CARDIOVASCULAR SYSTEMS | 6-MINUTE WALK TEST | FUNCTIONAL-CAPACITY | CIRCULATORY SUPPORT | TRANSPLANTATION | ADVANCED HEART-FAILURE | PERIPHERAL VASCULAR DISEASE | EXPERIENCE | PATIENT | OUTCOMES | QUESTIONNAIRE | VALIDITY | Severity of Illness Index | Humans | Male | Treatment Outcome | Automobile Driving - psychology | Ventricular Dysfunction, Left - psychology | Sexual Behavior - psychology | Heart Failure - therapy | Ventricular Dysfunction, Left - therapy | Female | Quality of Life - psychology | Heart-Assist Devices - psychology | Sexual Behavior - physiology | Heart Failure - psychology | Heart diseases | Care and treatment | Patient outcomes
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2016, Volume 35, Issue 8, pp. 1003 - 1009
Background Stroke is one of the leading complications during continuous flow-left ventricular assist device (CF-LVAD) support. Risk factors have been well...
Surgery | intracerebral hemorrhage | continuous flow | transplant eligibility | left ventricular assist device | stroke | ischemic stroke | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | EVENTS | HEMORRHAGE | HEART-FAILURE | GUIDELINES | CIRCULATORY SUPPORT | HEALTH-CARE PROFESSIONALS | CEREBROVASCULAR-DISEASE | TRANSPLANTATION | RESPIRATORY SYSTEM | ASSOCIATION | Brain Ischemia | Stroke | Hospital Mortality | Humans | Heart Failure | Treatment Outcome | Retrospective Studies | Heart-Assist Devices | Epidemiology
Surgery | intracerebral hemorrhage | continuous flow | transplant eligibility | left ventricular assist device | stroke | ischemic stroke | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | EVENTS | HEMORRHAGE | HEART-FAILURE | GUIDELINES | CIRCULATORY SUPPORT | HEALTH-CARE PROFESSIONALS | CEREBROVASCULAR-DISEASE | TRANSPLANTATION | RESPIRATORY SYSTEM | ASSOCIATION | Brain Ischemia | Stroke | Hospital Mortality | Humans | Heart Failure | Treatment Outcome | Retrospective Studies | Heart-Assist Devices | Epidemiology
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2014, Volume 33, Issue 1, pp. 51 - 59
Background Continuous-flow left ventricular assist devices (CF-LVADs) are increasingly used to support patients with advanced heart failure (HF). Device...
Surgery | lactate dehydrogenase | left ventricular assist device | advanced heart failure | international normalized ratio | coagulation | device thrombosis | Left ventricular assist device | Lactate dehydrogenase | Advanced heart failure | Device thrombosis | Coagulation | International normalized ratio | SURVIVAL | SURGERY | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | DESTINATION THERAPY | PREVALENCE | FAILURE | TRANSPLANTATION | SUPPORT | IMPLANTATION | RESPIRATORY SYSTEM | EXPERIENCE | PATIENT | OUTCOMES | Prevalence | Humans | Middle Aged | Heart Failure - physiopathology | Male | Heart-Assist Devices - adverse effects | Heart Failure - blood | Creatine - blood | Heart Failure - therapy | Ventricular Dysfunction, Left - therapy | Ventricular Dysfunction, Left - blood | Adult | Female | Retrospective Studies | Thrombosis - prevention & control | Risk Factors | Anticoagulants - therapeutic use | Thrombosis - epidemiology | Biomarkers - blood | Ventricular Dysfunction, Left - physiopathology | Bilirubin - blood | Algorithms | L-Lactate Dehydrogenase - blood | Thrombosis - etiology | Transaminases - blood | Aged | Heart failure | Thrombosis | Cardiac patients | Public health | Blood clot
Surgery | lactate dehydrogenase | left ventricular assist device | advanced heart failure | international normalized ratio | coagulation | device thrombosis | Left ventricular assist device | Lactate dehydrogenase | Advanced heart failure | Device thrombosis | Coagulation | International normalized ratio | SURVIVAL | SURGERY | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | DESTINATION THERAPY | PREVALENCE | FAILURE | TRANSPLANTATION | SUPPORT | IMPLANTATION | RESPIRATORY SYSTEM | EXPERIENCE | PATIENT | OUTCOMES | Prevalence | Humans | Middle Aged | Heart Failure - physiopathology | Male | Heart-Assist Devices - adverse effects | Heart Failure - blood | Creatine - blood | Heart Failure - therapy | Ventricular Dysfunction, Left - therapy | Ventricular Dysfunction, Left - blood | Adult | Female | Retrospective Studies | Thrombosis - prevention & control | Risk Factors | Anticoagulants - therapeutic use | Thrombosis - epidemiology | Biomarkers - blood | Ventricular Dysfunction, Left - physiopathology | Bilirubin - blood | Algorithms | L-Lactate Dehydrogenase - blood | Thrombosis - etiology | Transaminases - blood | Aged | Heart failure | Thrombosis | Cardiac patients | Public health | Blood clot
Journal Article
Artificial Organs, ISSN 0160-564X, 07/2018, Volume 42, Issue 7, pp. 695 - 699
Literature on driving capacities of ventricular assist device patients is rare and driving restrictions differ from center to center. Currently, no guidelines...
Left ventricular assist device | Driving | Quality of life | ENGINEERING, BIOMEDICAL | ADULTS | CIRCULATORY SUPPORT | TRANSPLANTATION | CARDIOVERTER-DEFIBRILLATORS | HEART-FAILURE PATIENTS | PATIENT | QUALITY-OF-LIFE | ASSOCIATION UPDATED RECOMMENDATIONS | CONSENSUS STATEMENT | Automobile driving | Motor vehicle driving | Heart | Medical personnel | Complications | Driving ability | Alarms | Implantation | Casualties | Ventricle | Patients | Doctors | Accidents
Left ventricular assist device | Driving | Quality of life | ENGINEERING, BIOMEDICAL | ADULTS | CIRCULATORY SUPPORT | TRANSPLANTATION | CARDIOVERTER-DEFIBRILLATORS | HEART-FAILURE PATIENTS | PATIENT | QUALITY-OF-LIFE | ASSOCIATION UPDATED RECOMMENDATIONS | CONSENSUS STATEMENT | Automobile driving | Motor vehicle driving | Heart | Medical personnel | Complications | Driving ability | Alarms | Implantation | Casualties | Ventricle | Patients | Doctors | Accidents
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2011, Volume 30, Issue 8, pp. 849 - 853
Background In this study we investigated gastrointestinal (GI) bleeding and its relationship to arteriovenous malformations (AVMs) in patients with the...
Surgery | arteriovenous malformation | heart assist device | gastrointestinal bleeding | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | RESPIRATORY SYSTEM | AORTIC-STENOSIS | ANGIODYSPLASIA | CLINICAL-EXPERIENCE | TRANSPLANTATION | Plasma | Prevalence | Erythrocyte Transfusion | Humans | Middle Aged | Anticoagulants - therapeutic use | Male | Treatment Outcome | Anticoagulants - adverse effects | Withholding Treatment | Arteriovenous Malformations - complications | Gastrointestinal Hemorrhage - epidemiology | Arteriovenous Malformations - epidemiology | Young Adult | Ventricular Dysfunction, Left - therapy | Thromboembolism - prevention & control | Gastrointestinal Hemorrhage - etiology | Adolescent | Gastrointestinal Hemorrhage - therapy | Adult | Female | Aged | Retrospective Studies | Heart-Assist Devices | Gastrointestinal bleeding | Care and treatment
Surgery | arteriovenous malformation | heart assist device | gastrointestinal bleeding | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | RESPIRATORY SYSTEM | AORTIC-STENOSIS | ANGIODYSPLASIA | CLINICAL-EXPERIENCE | TRANSPLANTATION | Plasma | Prevalence | Erythrocyte Transfusion | Humans | Middle Aged | Anticoagulants - therapeutic use | Male | Treatment Outcome | Anticoagulants - adverse effects | Withholding Treatment | Arteriovenous Malformations - complications | Gastrointestinal Hemorrhage - epidemiology | Arteriovenous Malformations - epidemiology | Young Adult | Ventricular Dysfunction, Left - therapy | Thromboembolism - prevention & control | Gastrointestinal Hemorrhage - etiology | Adolescent | Gastrointestinal Hemorrhage - therapy | Adult | Female | Aged | Retrospective Studies | Heart-Assist Devices | Gastrointestinal bleeding | Care and treatment
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 11/2017, Volume 36, Issue 11, pp. 1164 - 1173
Over the past decade, continuous-flow rotary pumps have dramatically improved survival for patients with advanced systolic heart failure. Bleeding and...
anti-thrombotic therapy | thrombosis | hemolysis | left ventricular assisted device | gastrointestinal bleeding | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | PUMP THROMBOSIS | PLATELET-ADHESION | CENTRIFUGAL PUMP | VON-WILLEBRAND-FACTOR | TRANSPLANTATION | ADVANCED HEART-FAILURE | INTERAGENCY REGISTRY | MATE II | CARBON-MONOXIDE | RESPIRATORY SYSTEM | CONTINUOUS-FLOW | ADVERSE EVENTS | Heart Failure - surgery | Gastrointestinal Hemorrhage - etiology | Thrombosis - etiology | Gastrointestinal Hemorrhage - blood | Humans | Heart-Assist Devices - adverse effects | Blood Coagulation - physiology | Thrombosis - blood | Postoperative Complications | von Willebrand Factor - metabolism | Heart failure | Stroke (Disease) | Thrombosis | Cardiac patients | Blood clot | Von Willebrand factor
anti-thrombotic therapy | thrombosis | hemolysis | left ventricular assisted device | gastrointestinal bleeding | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | PUMP THROMBOSIS | PLATELET-ADHESION | CENTRIFUGAL PUMP | VON-WILLEBRAND-FACTOR | TRANSPLANTATION | ADVANCED HEART-FAILURE | INTERAGENCY REGISTRY | MATE II | CARBON-MONOXIDE | RESPIRATORY SYSTEM | CONTINUOUS-FLOW | ADVERSE EVENTS | Heart Failure - surgery | Gastrointestinal Hemorrhage - etiology | Thrombosis - etiology | Gastrointestinal Hemorrhage - blood | Humans | Heart-Assist Devices - adverse effects | Blood Coagulation - physiology | Thrombosis - blood | Postoperative Complications | von Willebrand Factor - metabolism | Heart failure | Stroke (Disease) | Thrombosis | Cardiac patients | Blood clot | Von Willebrand factor
Journal Article